Zota invests ₹2.10 crore in Ugo Generic retail subsidiary
As filed · ZOTA: Zota Health Care Limited has informed the Exchange about Acquisition of 21,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary of the Company, by way of subscription to th
What happened
FactZota Health Care subscribed to 21,00,000 equity shares of its wholly owned subsidiary, KMHP Ventures Limited, through a rights issue at ₹10.00 per share, investing ₹2,10,00,000. KMHP Ventures remains a wholly owned subsidiary and is planning the Ugo Generic pharmacy retail rollout across B2B and B2C channels.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
WithdrawnFor the 803 stores opened during FY26, the average monthly sales per store in Q1 stood at approximately INR1.61 lakh.
The encouraging aspect is that newer stores are actually performing marginally better than older store cohorts.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
- We expect this quarterly cash loss of around INR20 crore to be eliminated over the next two to three quarters (management committed by Q4 FY27)
- For example, last year we opened around 600 COCO stores, and this year we are planning to open approximately 8 (management committed by FY26)
Evidence
- ZOTA: Zota Health Care Limited has informed the Exchange about Acquisition of 21,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY26
How CapitSignal classified this
- Reasoning:
- The funding supports expansion of the Ugo Generic retail-store chain and working-capital needs of a newly incorporated subsidiary with no reported FY 2025-26 turnover. The planned model includes owned stores and onboarding approximately 12.5 lakhs retail pharmacies.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%